🎯 check Adavosertib (AZD1775, MK-1775) product page
Adavosertib is a potent, selective ATP-competitive Wee1 inhibitor. It affects cell cycle and DNA damage response signaling by reducing CDK1 phosphorylation and abrogating the G2/M checkpoint, effectively inhibiting tumor cell proliferation and promoting apoptosis.